Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
86.25
+1.60 (1.89%)
Jun 26, 2026, 4:00 PM EDT - Market closed

Globus Medical Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Globus Medical stock have an average target of 109.91, with a low estimate of 95 and a high estimate of 123. The average target predicts an increase of 27.43% from the current stock price of 86.25.

Analyst Consensus: Buy
Target Low Average Median High
Price $95 $109.91 $115 $123
Change +10.14% +27.43% +33.33% +42.61%

Analyst Ratings

The average analyst rating for Globus Medical stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 666566
Buy 554433
Hold 444444
Sell 000000
Strong Sell 000000
Total 151514131313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Hold
Maintains
n/a
Hold Maintains n/a n/a Jun 23, 2026
TD Cowen
TD Cowen
Buy
Maintains
$115
Buy Maintains $115 +33.33% Jun 22, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$115$100
Buy Maintains $115$100 +15.94% Jun 15, 2026
Barclays
Barclays
Buy
Maintains
$123
Buy Maintains $123 +42.61% May 11, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
Buy Maintains n/a n/a May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.20B
from 2.94B
Increased by 8.98%
Revenue Next Year
3.40B
from 3.20B
Increased by 6.29%
EPS This Year
4.74
from 3.98
Increased by 19.17%
EPS Next Year
5.15
from 4.74
Increased by 8.48%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
958.10M1.02B1.57B2.52B2.94B3.20B3.40B
Revenue Growth
21.43%6.76%53.35%60.62%16.65%8.98%6.29%
EPS
1.441.851.070.753.923.904.28
EPS Growth
42.57%28.47%-42.16%-29.91%422.67%-0.47%9.74%
Forward PE
-----22.1120.15
No. Analysts -----1313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 3.2B 3.5B
Avg 3.2B 3.4B
Low 3.2B 3.4B

Revenue Growth

Revenue Growth 202620272028
High
9.6%
8.5%
Avg
9.0%
6.3%
Low
8.6%
5.1%

EPS Forecast

EPS 202620272028
High 4.78 5.30
Avg 4.74 5.15
Low 4.70 4.93

EPS Growth

EPS Growth 202620272028
High
20.1%
11.7%
Avg
19.2%
8.5%
Low
18.1%
3.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.